Clonal spread of resistant pneumococci despite diminished antimicrobial use

被引:47
作者
Arason, VA
Gunnlaugsson, A
Sigurdsson, JA
Erlendsdottir, H
Gudmundsson, S
Kristinsson, KG
机构
[1] Landspitali Univ Hosp, Dept Clin Microbiol, IS-121 Reykjavik, Iceland
[2] Univ Iceland, Dept Family Med, Hafnarfjordur, Iceland
[3] Directorate Publ Hlth, Reykjavik, Iceland
来源
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE | 2002年 / 8卷 / 03期
关键词
D O I
10.1089/107662902760326896
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The effects of community-wide interventions to reduce resistance rates are poorly understood. This study evaluated the effect of reduced antimicrobial usage on the spread of penicillin-nonsusceptible pneumococci (PNSP) in four communities in Iceland. The study was performed after interventions to reduce antimicrobial usage and compared to an identical study performed 5 years before. A randomized sample of 953 children was chosen from all 2,900 1- to 6-year-old children living in four well-defined communities. The main outcome measures were nasopharyngeal carriage of PNSP and individual and community use of antimicrobials. Pneumococci were carried by 51.7% of the 743 children enrolled, and 8.1% of the pneumococci were PNSP as opposed to 8.5% in the previous study. The antimicrobial use of participants had been reduced from 1.5 to 1.1 courses/year and the overall use among children <7 years old living in the study areas from 13.6 to 11.1 defined daily dosages/1000 children per day. The prevalence of PNSP increased in the two areas furthest away from the capital area despite reduced consumption. The major risk factors for carriage of PNSP remained the same. Interventions can be effective in reducing antimicrobial use. Pandemic multiresistant clones can also spread fast in small communities with low antimicrobial use, where their appearance may be delayed compared to highly populated urban areas. Clonal spread and herd immunity are important factors to be considered in the evaluation of intervention effects.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 21 条
[1]  
Arason VA, 1996, BMJ-BRIT MED J, V313, P387
[2]   The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance [J].
Austin, DJ ;
Kristinsson, KG ;
Anderson, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1152-1156
[3]   Limiting the spread of penicillin-resistant Streptococcus pneumoniae: Experiences from the south Swedish pneumococcal intervention project [J].
Ekdahl, K ;
Hansson, HB ;
Molstad, S ;
Soderstrom, M ;
Walder, M ;
Persson, K .
MICROBIAL DRUG RESISTANCE, 1998, 4 (02) :99-105
[4]   Low dosage and long treatment duration of β-lactam -: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae [J].
Guillemot, D ;
Carbon, C ;
Balkau, B ;
Geslin, P ;
Lecoeur, H ;
Vauzelle-Kervroëdan, F ;
Bouvenot, G ;
Eschwége, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (05) :365-370
[5]  
Jorgenson J. H., 1999, MANUAL CLIN MICROBIO, P1526
[6]   Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci [J].
Kristinsson, KG .
MICROBIAL DRUG RESISTANCE, 1997, 3 (02) :117-123
[7]   Epidemiology of penicillin resistant pneumococci in Iceland [J].
Kristinsson, KG .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (02) :121-125
[8]   INCREASING PENICILLIN RESISTANCE IN PNEUMOCOCCI IN ICELAND [J].
KRISTINSSON, KG ;
HJALMARSDOTTIR, MA ;
STEINGRIMSSON, O .
LANCET, 1992, 339 (8809) :1606-1607
[9]  
KRISTINSSON KG, 1999, CLIN MICROBIOL INFEC, V5, P43
[10]  
KRISTINSSON KG, 2000, STREPTOCOCCUS PNEUMO, P419